| Literature DB >> 27889388 |
Daniel C Berry1, Yuwei Jiang2, Robert W Arpke3, Elizabeth L Close4, Aki Uchida4, David Reading5, Eric D Berglund4, Michael Kyba6, Jonathan M Graff7.
Abstract
Cold temperatures induce progenitor cells within white adipose tissue to form beige adipocytes that burn energy and generate heat; this is a potential anti-diabesity therapy. However, the potential to form cold-induced beige adipocytes declines with age. This creates a clinical roadblock to potential therapeutic use in older individuals, who constitute a large percentage of the obesity epidemic. Here we show that aging murine and human beige progenitor cells display a cellular aging, senescence-like phenotype that accounts for their age-dependent failure. Activating the senescence pathway, either genetically or pharmacologically, in young beige progenitors induces premature cellular senescence and blocks their potential to form cold-induced beige adipocytes. Conversely, genetically or pharmacologically reversing cellular aging by targeting the p38/MAPK-p16Ink4a pathway in aged mouse or human beige progenitor cells rejuvenates cold-induced beiging. This in turn increases glucose sensitivity. Collectively, these data indicate that anti-aging or senescence modalities could be a strategy to induce beiging, thereby improving metabolic health in aging humans.Entities:
Keywords: Ink4a/Arf; adipose; beige adipocytes; cellular aging; cold exposure; mural cells; senescence; thermogenesis
Mesh:
Substances:
Year: 2016 PMID: 27889388 PMCID: PMC5226893 DOI: 10.1016/j.cmet.2016.10.023
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287